WallStreetZenWallStreetZen

NASDAQ: AGIO
Agios Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Agios Pharmaceuticals revenue was $36.50M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $10.7M, up 19.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AGIO annual revenue was $36.5M, with 36.1% growth year-over-year.

AGIO past revenue growth

How has AGIO's revenue growth performed historically?

Company
36.07%
Industry
497.69%
Market
20.68%
AGIO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AGIO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AGIO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AGIO revenue history

Current Revenue
$36.5M
Current Earnings
$673.7M
Current Profit Margin
1,845.9%

Be the first to know when AGIO announces revenue.

AGIO Revenue History By Year

AGIO Yearly RevenueAGIO RevenueAGIO ChangeAGIO Revenue Growth
2024-12-31$36.50M$9.68M+36.07%
2023-12-31$26.82M$12.58M+88.36%
2022-12-31$14.24MN/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00-$94.39M-100.00%
2018-12-31$94.39M$51.38M+119.45%
2017-12-31$43.01M-$26.88M-38.46%
2016-12-31$69.89M$10.77M+18.22%
2015-12-31$59.12M-$6.24M-9.55%
2014-12-31$65.36M$39.81M+155.82%
2013-12-31$25.55M$442.00k+1.76%
2012-12-31$25.11M$3.27M+14.97%
2011-12-31$21.84MN/AN/A

1 of 1

Agios Pharmaceuticals Revenue FAQ

What was AGIO's revenue last quarter?

On Invalid Date, Agios Pharmaceuticals (NASDAQ: AGIO) reported Q4 2024 revenue of $10.73 million up 51.06% year over year. In the same quarter last year, Agios Pharmaceuticals's revenue was $7.10 million.

What was Agios Pharmaceuticals's revenue in 2024?

Agios Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $36.50 million, a 36.07% increase year over year.

How much does Agios Pharmaceuticals make in a day?

Based on Agios Pharmaceuticals annual revenue for the past five years, AGIO makes an average of $42,499.18 per day.

What was Agios Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Agios Pharmaceuticals's revenue has grown 36.07% year over year. This is 461.62 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Agios Pharmaceuticals's revenue in the past year totaled $36.50 million.

How much does Agios Pharmaceuticals make in a year?

Agios Pharmaceuticals's revenue by year for the past five years is:
  • Agios Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $36.50 million, a 36.07% increase year over year.
  • Agios Pharmaceuticals's annual revenue for Dec 31, 2023 was $26.82 million, a 88.36% increase from 2022.
  • Agios Pharmaceuticals's annual revenue for 2022 was $14.24 million, a Infinity% increase from 2021.
  • Agios Pharmaceuticals's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Agios Pharmaceuticals's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.